Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens

Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens

Background: Drug-resistant tuberculosis (DR-TB) continues to be a global threat. Moxifloxacin is one of the components of the shorter treatment regimen which is suspected to increase the risk of QT prolongation, although it is also likely to be the most effective against DR-TB. A study to evaluate t...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Tutik Kusmiati, Ni Made Mertaniasih, Johanes Nugroho Eko Putranto, Budi Suprapti, Nadya Luthfah, Soedarsono Soedarsono, Winariani Koesoemoprodjo, Aryani Prawita Sari
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Elsevier 2022-08-01
Seri Bilgileri:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Konular:
Drug-resistant tuberculosis
Shorter treatment regimen
Moxifloxacin concentration
QTc interval
Online Erişim:http://www.sciencedirect.com/science/article/pii/S2405579422000250

Internet

http://www.sciencedirect.com/science/article/pii/S2405579422000250

Benzer Materyaller